Alps Advisors Inc Kura Oncology, Inc. Transaction History

Alps Advisors Inc

$14.8 Billion
Q3 2024

A detailed history of Alps Advisors Inc transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Alps Advisors Inc holds 58,695 shares of KURA stock, worth $630,971. This represents 0.01% of its overall portfolio holdings.

Number of Shares

58,695

Previous 59,403 1.19%

Holding current value

$630,971

Previous $1.22 Million 6.3%

% of portfolio

0.01%

Previous 0.01%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$18.57 - $23.23 $13,147 - $16,446	-708 Reduced 1.19%	58,695 $1.15 Million
Q2 2024 Aug 13, 2024	BUY	$17.53 - $22.98 $99,973 - $131,054	5,703 Added 10.62%	59,403 $1.22 Million
Q1 2024 May 14, 2024	BUY	$13.42 - $23.53 $43,225 - $75,790	3,221 Added 6.38%	53,700 $1.15 Million
Q4 2023 Feb 14, 2024	SELL	$7.58 - $14.38 $32,366 - $61,402	-4,270 Reduced 7.8%	50,479 $725,000
Q3 2023 Nov 14, 2023	BUY	$8.44 - $11.86 $37,482 - $52,670	4,441 Added 8.83%	54,749 $499,000
Q2 2023 Aug 14, 2023	BUY	$9.62 - $13.99 $50,168 - $72,957	5,215 Added 11.56%	50,308 $532,000
Q1 2023 May 10, 2023	SELL	$10.71 - $14.6 $12,637 - $17,228	-1,180 Reduced 2.55%	45,093 $551,000
Q4 2022 Feb 14, 2023	BUY	$11.23 - $16.9 $110,121 - $165,721	9,806 Added 26.89%	46,273 $574,000
Q3 2022 Nov 14, 2022	SELL	$12.01 - $19.45 $36,726 - $59,478	-3,058 Reduced 7.74%	36,467 $498,000
Q2 2022 Aug 11, 2022	BUY	$10.71 - $18.33 $423,312 - $724,493	39,525 New	39,525 $724,000
Q4 2020 Feb 03, 2021	SELL	$29.0 - $41.62 $2.08 Million - $2.99 Million	-71,775 Closed	0 $0
Q3 2020 Nov 04, 2020	SELL	$16.3 - $30.64 $42,575 - $80,031	-2,612 Reduced 3.51%	71,775 $2.2 Million
Q2 2020 Aug 05, 2020	SELL	$7.95 - $18.81 $63,623 - $150,536	-8,003 Reduced 9.71%	74,387 $1.21 Million
Q1 2020 May 06, 2020	SELL	$6.45 - $14.04 $61,926 - $134,798	-9,601 Reduced 10.44%	82,390 $820,000
Q4 2019 Feb 07, 2020	BUY	$12.97 - $15.94 $24,370 - $29,951	1,879 Added 2.09%	91,991 $1.27 Million
Q3 2019 Nov 04, 2019	BUY	$14.75 - $20.87 $150,214 - $212,540	10,184 Added 12.74%	90,112 $1.37 Million
Q2 2019 Aug 07, 2019	SELL	$14.71 - $19.79 $175,710 - $236,391	-11,945 Reduced 13.0%	79,928 $1.57 Million
Q1 2019 May 01, 2019	BUY	$13.73 - $16.87 $54,563 - $67,041	3,974 Added 4.52%	91,873 $1.52 Million
Q4 2018 Feb 04, 2019	BUY	$10.6 - $17.49 $219,398 - $362,008	20,698 Added 30.8%	87,899 $1.23 Million
Q3 2018 Oct 25, 2018	BUY	$16.65 - $21.85 $313,036 - $410,801	18,801 Added 38.85%	67,201 $1.18 Million
Q2 2018 Aug 02, 2018	BUY	$14.8 - $18.8 $220,771 - $280,439	14,917 Added 44.55%	48,400 $881,000
Q2 2018 Jul 25, 2018	SELL	$14.8 - $18.8 $104,236 - $132,408	-7,043 Reduced 17.38%	33,483 $512,000
Q1 2018 May 01, 2018	BUY	$14.5 - $23.4 $102,123 - $164,806	7,043 Added 21.03%	40,526 $760,000
Q4 2017 Feb 05, 2018	BUY	$13.5 - $16.65 $452,020 - $557,491	33,483	33,483 $512,000

Others Institutions Holding KURA

# of Institutions

185

Shares Held

81.8M

Call Options Held

42.1K

Put Options Held

34K

View Full List

About Kura Oncology, Inc.

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $719M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

More about KURA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Account

Alps Advisors Inc Kura Oncology, Inc. Transaction History